A Showcase of Innovation

Skåne Capital Day will feature pitches from 10 cutting-edge startups, each offering unique solutions across various industries. Here’s a glimpse of what to expect:

• Hey Tilda: Increase the effect of your learning and change initiatives using AI.
• Meadow: A social platform for building, publishing & distributing AR and immersive content.
• LincSense: A software platform that gathers connectivity related metrics from IoT devices and delivers actionable insights.
• Ironic Biotech: Developing plant-based heme-iron supplements to address iron deficiency, promoting health and wellness.
• Seaqure Labs: Creating mycoproteins for the next generation of aquaculture, driving sustainability in seafood production.
• Nimt.ai: Offering tools to track and improve your share of voice and ranking on AI platforms, optimizing digital presence.
• Caiator: Revolutionizing industrial spare parts sales with AI agents, streamlining procurement processes.
• Travalytics: Providing seamless employee travel reporting tools, simplifying corporate travel management.
• Cognes: Leveraging machine learning for scalable early dementia detection, advancing healthcare diagnostics.
• Innoviguard: Delivering innovative online safety solutions, including the dynamic P55 ProGuard, ensuring digital security.

The event is invite-only, priority for investors.

• Date: 26th March, 2025
• Location: Krinova (Stridsvagnsvägen 14, 291 39 Kristianstad)
• Apply for access: Skåne Capital Day 

The post Join the Innovation Revolution at Skåne Capital Day – March 26th appeared first on Øresund Startups.

Ironic Biotech’s breakthrough involves the development of a new generation of plant-derived proteins that contain heme iron, known for its high bioavailability and lack of side effects. Produced through precision fermentation, these proteins can be integrated into foods or food supplements, offering an innovative and side-effect-free alternative to current iron supplements that are often associated with digestive issues and other adverse effects.

The company’s pioneering approach aims to fill a critical gap in the market for accessible and effective iron supplements.

“We want to help 2 billion people to prevent and recover from iron deficiency and anemia,”

says Dr. Nélida Leiva Eriksson, CEO and founder of Ironic Biotech

Dr. Eriksson, who herself has experienced the debilitating effects of iron deficiency, is determined to mitigate the performance gap attributed to iron loss, especially in women.

The quest for a sustainable iron supplement is also driven by environmental and health concerns associated with red meat consumption, traditionally considered the most significant source of iron. Ironic Biotech’s solution emerges as a timely response to the increasing adoption of plant-based diets, which, while beneficial for the planet, can exacerbate iron deficiency risks among women.

Louise Heiberg, Investment Director at Nordic Foodtech VC, highlights the significance of Ironic Biotech’s innovation in addressing iron uptake concerns and reducing red meat consumption. The early support from investors is crucial in building a strong foundation for the company’s success and scaling its impact.

Ironic Biotech’s proprietary compounds are designed to overcome the limitations of current iron supplements by offering a tasteless, stable, and highly absorbable iron source. This breakthrough promises to transform the food and supplement industry by making iron more accessible to those on predominantly plant-based diets and anyone struggling to maintain adequate iron levels.

Founded in 2020 by Dr. Nélida Leiva Eriksson, alongside Eskil Åhlin and Hans Holm, Ironic Biotech combines expertise in protein design, molecular biology, global business development, and innovation within the food ingredients and dietary supplement sectors. The team’s collective experience and dedication are poised to empower women and individuals worldwide, putting an end to the exhaustion associated with iron deficiency.

With this new funding, Ironic Biotech is set to expand its market presence, enhance its patent portfolio, and optimize production processes, laying the groundwork for partnerships within the food and food supplement industry. The future looks promising for those affected by iron deficiency and anemia, thanks to Ironic Biotech’s groundbreaking solution.

The post Ironic Biotech Secures €1M to Combat Global Iron Deficiency with Plant-Derived Solution appeared first on Øresund Startups.